ロード中...
Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
BACKGROUND: Long-term monotherapy with nucleos(t)ide analogs (NAs) represents the treatment option for the majority of patients with chronic hepatitis B (CHB), an aging population with a greater likelihood of comorbidities. We assessed the prevalence of concurrent non-hepatic diseases and the safety...
保存先:
| 出版年: | Ann Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hellenic Society of Gastroenterology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7774663/ https://ncbi.nlm.nih.gov/pubmed/33414625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2020.0525 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|